A pharmacodynamic study of 5-azacytidine in the P39 cell line.
about
Equitoxic doses of 5-azacytidine and 5-aza-2'deoxycytidine induce diverse immediate and overlapping heritable changes in the transcriptomeLenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.SGI-110: DNA Methyltransferase Inhibitor OncolyticInferring a role for methylation of intergenic DNA in the regulation of genes aberrantly expressed in precursor B-cell acute lymphoblastic leukemia.DNA methylation inhibitor causes cell growth retardation and gene expression changes in feline lymphoma cells.A paediatric case of successful non-myeloablative bone marrow transplantation after azacitidine therapy for non-Down syndrome acute megakaryoblastic leukaemia with monosomy 7.
P2860
A pharmacodynamic study of 5-azacytidine in the P39 cell line.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A pharmacodynamic study of 5-azacytidine in the P39 cell line.
@en
type
label
A pharmacodynamic study of 5-azacytidine in the P39 cell line.
@en
prefLabel
A pharmacodynamic study of 5-azacytidine in the P39 cell line.
@en
P50
P1476
A pharmacodynamic study of 5-azacytidine in the P39 cell line.
@en
P2093
Eva Hellström-Lindberg
Rasheed Khan
P356
10.1016/J.EXPHEM.2005.09.007
P577
2006-01-01T00:00:00Z